Ensuring equity in the prevention of neglected tropical diseases (NTDs) is critical to reach NTD elimination goals as well as to inform Universal Health Coverage (UHC). Now, researchers have unmasked inequities in the delivery of Mass Drug Administration (MDA) programs that leave vulnerable populations underserved.